Messenger RNA and protein expression analysis of voltage‐gated potassium channels in the brain of Aβ25–35‐treated rats

Potassium channel dysfunction has been implicated in Alzheimer's disease. In the present study, the expression of voltage‐gated potassium channel (Kv) subunits in rat brain was measured after a single intracerebroventricular injection of β‐amyloid peptide 25–35 (Aβ25–35). After injection of Aβ, the spatial memory of rats was significantly impaired in the Morris water maze. Expression of five main Kv channel subunits (Kv1.5, Kv2.1, Kv1.4, Kv4.2, and Kv4.3) in mRNA level was assessed by using reverse transcription‐polymerase chain reaction (RT‐PCR). The mRNA levels of Kv2.1 and Kv1.4 were increased by 72% and 67%, respectively, in hippocampus, and Kv4.2 mRNA was increased by 58% in cortex. No other significant mRNA expression changes were found in Aβ‐treated rats. The protein expression of Kv2.1, Kv1.4, and Kv4.2 was detected by using Western blotting. Kv2.1 and Kv1.4 protein levels were increased by 48% and 50%, respectively, in hippocampus of Aβ‐treated rats, and Kv4.2 protein was increased by 42% in cerebral cortex. This study indicates that the expression up‐regulation of Kv1.4, Kv2.1, and Kv4.2 in Aβ‐induced cognitive impairment might play an important role in the pathogenesis of Alzheimer's disease. © 2004 Wiley‐Liss, Inc.

[1]  S. Appel,et al.  β‐Amyloid‐Induced Neurotoxicity of a Hybrid Septal Cell Line Associated with Increased Tau Phosphorylation and Expression of β‐Amyloid Precursor Protein , 1997 .

[2]  G. Glenner,et al.  Alzheimer's disease: initial report of the purification and characterization of a novel cerebrovascular amyloid protein. , 1984, Biochemical and biophysical research communications.

[3]  D. Selkoe The molecular pathology of Alzheimer's disease , 1991, Neuron.

[4]  T. Good,et al.  Beta-amyloid peptide blocks the fast-inactivating K+ current in rat hippocampal neurons. , 1996, Biophysical journal.

[5]  Chen-Hsiung Yeh,et al.  Enhancement of Outward Potassium Current May Participate in β-Amyloid Peptide-Induced Cortical Neuronal Death , 1998, Neurobiology of Disease.

[6]  D. Mann,et al.  Some morphometric observations on the cerebral cortex and hippocampus in presenile Alzheimer's disease, senile dementia of Alzheimer type and Down's syndrome in middle age , 1985, Journal of the Neurological Sciences.

[7]  L. Colom,et al.  Role of Potassium Channels in Amyloid‐Induced Cell Death , 1998, Journal of neurochemistry.

[8]  A. Privat,et al.  In vitro aggregation facilities beta-amyloid peptide-(25-35)-induced amnesia in the rat. , 1997, European journal of pharmacology.

[9]  A. Privat,et al.  In vitro aggregation facilitates β-amyloid peptide-(25–35)-induced amnesia in the rat , 1997 .

[10]  J. Nerbonne,et al.  Differential expression of voltage-gated K+ channel subunits in adult rat heart. Relation to functional K+ channels? , 1995, Circulation Research.

[11]  S. Shimohama Apoptosis in Alzheimer's disease—an update , 2000, Apoptosis.

[12]  J. Trimmer,et al.  Phosphorylation of the Kv2.1 K+ channel alters voltage-dependent activation. , 1997, Molecular pharmacology.

[13]  B. Rudy,et al.  Molecular Diversity of K+ Channels , 1999, Annals of the New York Academy of Sciences.

[14]  J. Jhamandas,et al.  Cellular mechanisms for amyloid beta-protein activation of rat cholinergic basal forebrain neurons. , 2001, Journal of neurophysiology.

[15]  R. Morris Developments of a water-maze procedure for studying spatial learning in the rat , 1984, Journal of Neuroscience Methods.

[16]  T. Ueda,et al.  Amyloid-β-protein (Aβ) (25–35)-associated free radical generation is strongly influenced by the aggregational state of the peptides , 2002 .

[17]  Rui Wang,et al.  Expression of voltage-dependent K+ channel genes in mesenteric artery smooth muscle cells. , 1999, American journal of physiology. Gastrointestinal and liver physiology.

[18]  S. Kawashima,et al.  Effects of amyloid-beta-(25-35) on passive avoidance, radial-arm maze learning and choline acetyltransferase activity in the rat. , 2001, European journal of pharmacology.

[19]  C. Ghelardini,et al.  Influence of potassium channel modulators on cognitive processes in mice , 1998, British journal of pharmacology.

[20]  T. Harkany,et al.  Mechanisms of ß-Amyloid Neurotoxicity: Perspectives of Pharmacotherapy , 2000, Reviews in the neurosciences.

[21]  J. Kourie Mechanisms of Amyloid β Protein-Induced Modification in Ion Transport Systems: Implications for Neurodegenerative Diseases , 2001, Cellular and Molecular Neurobiology.

[22]  T. Ueda,et al.  Amyloid-beta-protein (A beta) (25-35)-associated free radical generation is strongly influenced by the aggregational state of the peptides. , 2002, Life sciences.

[23]  Effects of beta-amyloid peptide on transient outward potassium current of acutely dissociated hippocampal neurons in CA1 sector in rats. , 1998, Chinese medical journal.

[24]  M. Mattson,et al.  Activation of K+ channels and suppression of neuronal activity by secreted β-amyloid-precursor protein , 1996, Nature.

[25]  E. Joe,et al.  β-amyloid peptide induces the expression of voltage dependent outward rectifying K+ channels in rat microglia , 2001, Neuroscience Letters.

[26]  A. Privat,et al.  Amnesia induced in mice by centrally administered β-amyloid peptides involves cholinergic dysfunction , 1996, Brain Research.

[27]  J Carter,et al.  Molecular Pathology of Alzheimer's Disease , 2013 .

[28]  L. Jarvik,et al.  Potassium Channel Blockers: Could They Work in Alzheimer Disease? , 1991, Alzheimer disease and associated disorders.

[29]  Y. Suh,et al.  Ionic effects of the Alzheimer's disease β-amyloid precursor protein and its metabolic fragments , 1997, Trends in Neurosciences.

[30]  J. Nerbonne,et al.  Mediation of Neuronal Apoptosis by Kv2.1-Encoded Potassium Channels , 2003, The Journal of Neuroscience.

[31]  John P. Blass,et al.  4-Aminopyridine in the treatment of alzheimer's disease , 1988, Biological Psychiatry.

[32]  S. Appel,et al.  Beta-amyloid-induced neurotoxicity of a hybrid septal cell line associated with increased tau phosphorylation and expression of beta-amyloid precursor protein. , 1997, Journal of neurochemistry.